MNOV Q4 2025 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena

MNOVMediciNova, Inc.

$69M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$151,739

Gross Profit

$51,75834.1% margin

Operating Income

-$3M-2038.0% margin

Net Income

-$3M-1846.8% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+23.0%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$338,255

Balance Sheet

Total Assets

$46M

Total Liabilities

$4M

Stockholders' Equity

$42M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$151,739	$0	—
Gross Profit	$51,758	-$5,177	+1099.8%
Operating Income	-$3M	-$3M	+2.9%
Net Income	-$3M	-$3M	+0.4%